calamine 30 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Lotion

RxCUI
1233698
RxNorm name
calamine 30 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Lotion
Display name
Calamine/Pramoxine (Topical)
Full name
calamine 30 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Lotion
Term type
SCD
Status
Active
Strength
3-1%
Dose form
Lotion
Route
Topical
Updated
2026-07-17 22:19:26

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
012012
Active start
012012
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
calamine30 MG / 1 MLcalaminecalamine
pramoxine hydrochloride10 MG / 1 MLpramoxinepramoxine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Lotion316983

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
calamine106212
pramoxine34347

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRcalamine 30 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Lotion1NAMES
RxNorm Namecalamine 30 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Lotion1NAMES
RxNorm Synonymcalamine 3 % / pramoxine hydrochloride 1 % Topical Lotion1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_ID07f4d4d0-9cee-46c3-bc71-2024abd31c9e1CODES
RxCUI12336981CODES
MMSL_CODE
2 linked values
2CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
69968-0475-469968-0475Aveeno Anti-Itch Concentrated Zinc Oxide, Ferric Oxide Red, and Pramoxine HydrochlorideKenvue Brands LLCM017

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M01769968-0475Aveeno Anti-Itch Concentrated Zinc Oxide, Ferric Oxide Red, and Pramoxine HydrochlorideOTC MONOGRAPH DRUGKenvue Brands LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 5 matching rows.

NDC11, Source, Active table
NDC11SourceActive
08137003690rxnav_ndcsyes
69968047504rxnav_ndcsyes
08137003680rxnav_historical_indirect
46500003420rxnav_historical_indirect
58232991002rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Aveeno Anti-Itch ConcentratedZINC OXIDE, FERRIC OXIDE RED, AND PRAMOXINE HYDROCHLORIDEKenvue Brands LLC07f4d4d0-9cee-46c3-bc71-2024abd31c9e2025-10-29WarningsExact identifier
ndc (package): 69968-0475-4
ndc (product): 69968-0475
ndc11 (package): 69968047504
rxcui: 1233698

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
07f4d4d0-9cee-46c3-bc71-2024abd31c9ecalamine 3 % / pramoxine HCl 1 % Topical Lotion [PSN] · calamine 30 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Lotion [SCD] · calamine 3 % / pramoxine hydrochloride 1 % Topical Lotion [SY]36Aveeno ® Anti-Itch CONCENTRATED LOTION20251029

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
07f4d4d0-9cee-46c3-bc71-2024abd31c9eAveeno ® Anti-Itch CONCENTRATED LOTIONKenvue Brands LLC20251029
07f4d4d0-9cee-46c3-bc71-2024abd31c9eAveeno ® Anti-Itch CONCENTRATED LOTIONKenvue Brands LLC20241105
399664e9-8799-4a94-85bf-0c3825f42a0cAveeno Anti-Itch Concentrated LotionJohnson & Johnson Consumer Inc.20190103

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD04ABAnesthetics for topical useATC1-4pramoxine
ATCC05ADLocal anestheticsATC1-4pramoxine
MEDRTD009025MorpholinesCHEMhas_ingredientpramoxine hydrochloride
MEDRTD009025MorpholinesCHEMhas_ingredientpramoxine
MEDRTD003877Dermatitis, ContactDISEASEmay_treatpramoxine hydrochloride
MEDRTD003877Dermatitis, ContactDISEASEmay_preventcalamine
MEDRTD003877Dermatitis, ContactDISEASEmay_treatpramoxine
MEDRTD004342Drug HypersensitivityDISEASEci_withcalamine
MEDRTD004342Drug HypersensitivityDISEASEci_withpramoxine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withpramoxine
MEDRTD005401Fissure in AnoDISEASEmay_treatpramoxine
MEDRTD005401Fissure in AnoDISEASEmay_treatpramoxine hydrochloride
MEDRTD006484HemorrhoidsDISEASEmay_treatpramoxine
MEDRTD006484HemorrhoidsDISEASEmay_treatpramoxine hydrochloride
MEDRTD010146PainDISEASEmay_treatpramoxine
MEDRTD010146PainDISEASEmay_treatpramoxine hydrochloride
MEDRTD010939Plant PoisoningDISEASEmay_preventcalamine
MEDRTD011537PruritusDISEASEmay_treatpramoxine hydrochloride
MEDRTD011537PruritusDISEASEmay_treatpramoxine
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moapramoxine
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moacalamine
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moapramoxine hydrochloride
MEDRTN0000008301Astringent ActivityPEhas_pecalamine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pepramoxine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pepramoxine hydrochloride
MEDRTN0000010282Skin Barrier ActivityPEhas_pecalamine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH30 MG/ML / 10 MG/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
NAMESPrescribable Synonymcalamine 3 % / pramoxine HCl 1 % Topical Lotion
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary